References
1. von Pirqet C, Schick BT. Serum Sickness. Baltimore, MD: Williams & Wilkins Co; 1951.
2. Lawley TJ, Bielory L, Gascon P, Yancey KB, Young NS, Frank MM. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 1984;311(22):1407-1413.
3. Vaughan JH, Barnett EV, Leadley PJ. Serum sickness. Evidence in man of antigen-antibody complexes and free light chains in the circulation during the acute reaction. Ann Intern Med. 1967;67(3):596-602.
4. Heckbert SR, Stryker WS, Coltin KL, Manson JE, Platt R. Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol. 1990;132(2):336-342.
5. Kearns GL, Wheeler JG, Childress SH, Letzig LG. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr. 1994;125(5 Pt 1):805-811.
6. Platt R, Dreis MW, Kennedy DL, Kuritsky JN. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. J Infect Dis. 1988;158(2):474-477.
7. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet. 2000;356(9241):1587-1591.
8. Khan DA. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Ann Allergy Asthma Immunol.2016;117(2):115-120.
9. Yorulmaz A, Akin F, Sert A, Agir MA, Yilmaz R, Arslan S. Demographic and clinical characteristics of patients with serum sickness-like reaction. Clin Rheumatol. 2018;37(5):1389-1394.
10. Finger E, Scheinberg M. Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia. J Clin Rheumatol. 2007;13(2):94-95.
11. Elzagallaai AA, Greff M, Rieder MJ. Adverse Drug Reactions in Children: The Double-Edged Sword of Therapeutics. Clin Pharmacol Ther. 2017;101(6):725-735.
12. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991-1045.
13. Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D. Drug hypersensitivity reactions: pathomechanism and clinical symptoms.Med Clin North Am. 2010;94(4):645-664, xv.
14. Elzagallaai AA, Jahedmotlagh Z, Del Pozzo-Magana BR, et al. Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome. Mol Diagn Ther.2010;14(5):317-322.
15. Elzagallaai AA, Rieder MJ, Koren G. The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome. J Clin Pharmacol. 2011;51(3):428-435.
16. Surtees SJ, Stockton MG, Gietzen TW. Allergy to penicillin: fable or fact? Bmj. 1991;302(6784):1051-1052.
17. Kearns GL, Wheeler JG, Rieder MJ, Reid J. Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef.Clin Pharmacol Ther. 1998;63(6):686-693.
Legends to figures: